Top Abstract Purchase Related
Home
>
Node
>
Subnode

Host-tumor relationship XXXIII. Inhibitor of hyaluronidase in blood serum of cancer patients

Kolárová, M.

Neoplasma 22(4): 435-439

1975

ISSN/ISBN: 0028-2685
PMID: 630
Document Number: 85551
Inhibiting activity of blood serum was determined from the decrease of N-acetyl-hexosamine end groups of hyaluronic acid products released by testicular hyaluronidase. Maximum inhibition was observed within the region of pH from 6.5 to 6.8. Correlation between the serum concentration and its inhibiting effect on hyaluronidase was found within the range of the final dilution of serum (in the reaction mixture) from 9 to 45 X. Blood sera of cancer patients showed statistically significant increase of hyaluronidase inhibitor as compared with that of health people.

Document emailed within 1 workday
Secure & encrypted payments

Kolárová, M.; Tobiska, J.; Brada, Z. 1970: Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer Neoplasma 17(6): 641-648
Tanino, T.; Tsumita, T. 1972: Studies on the tumor-host relationship. IV. Tumor cell agglutination with survival mouse serum Japanese Journal of Experimental Medicine 42(4): 401-413
Reddy, J.M.; Joyce, C.; Zaneveld, L.J.D. 1980: Role of Hyaluronidase in Fertilization: the Antifertility Activity of Myocrisin, a Nontoxic Hyaluronidase Inhibitor Journal of Andrology 1(1): 28-32
Yunusova, N.V.; Kondakova, I.V.; Kolomiets, L.A.; S G Afanasiev; Chernyshova, A.L.; Shatokhina, O.V.; Frolova, A.E.; Zhou, Z.; Wang, W. 2015: Serum adipokines and their receptors in endometrial and colon cancer patients: relationship with tumor invasion and metastasis Voprosy Onkologii 61(4): 619-623
D'iachkova, A.I.; Berezovskaia, N.N. 1973: Determination of the hyaluronidase activity in blood serum Laboratornoe Delo 6: 360-362
Nakagoe, T.; Sawai, T.; Tsuji, T.; Jibiki, M.; Ohbatake, M.; Nanashima, A.; Yamaguchi, H.; Kurosaki, N.; Yasutake, T.; Ayabe, H.; Arisawa, K. 2001: Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer Journal of Experimental and Clinical Cancer Research: Cr 20(1): 85-90
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139
Trusova, N.F.; Tsigikian, T.A.; Shaternikov, V.A. 1973: Proteolytic activity and content of trypsin inhibitor in the blood serum of patients with leukemia Laboratornoe Delo 9: 546-549
Matić-Petrović, S.; Pucar, A.; Jotić, A.; Miličić, B.; Arambašić-Jovanović, J.; Vidaković, M.; Leković, V. 2016: Relationship between serum tumor necrosis factor receptor-2 concentration and periodontal destruction in patients with type 2 diabetes: Cross-sectional study Srpski Arhiv Za Celokupno Lekarstvo 144(5-6): 266-272
Dudenko, G.N.; Kozhuchko, V.G. 1979: Trypsin inhibitor system and free amino acids in blood serum in patients with history of gastric resection for ulcer disease depending on the type of surgery Klinicheskaia Khirurgiia 1979(8): 58-59
Szajda, S.ła.D.; Darewicz, B.; Kudelski, J.; Chlabicz, M.; Domel, T.; Chabielska, E.; Skrzydlewski, Z.ła. 2005: Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(108): 651-653
Petit, J.M.; Vaillant, G.; Olsson, N.O.; Guignier, F.; Collignon, S.; Verges, B.; Brun, J.M. 1994: Elevated serum CA19-9 levels in poorly controlled diabetic patients. Relationship with Lewis blood group Gastroenterologie Clinique et Biologique 18(1): 17-20
Kizawa, I.; Kikuchi, Y.; Kato, K. 1983: Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary Nihon Sanka Fujinka Gakkai Zasshi 35(3): 251-258
Mujagić, Z.; Mujagic, H.; Prnjavorac, B. 2004: The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients Medicinski Arhiv 58(1): 23-26
Xu, C.-a.; Su, H.; Liu, J.-l.; Li, L.; Zou, H.-w. 2011: Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor Zhonghua Zhong Liu Za Zhi 33(6): 436-441
Schuurman, J.J.; Bong, S.B.; Einarsson, R. 1996: Determination of serum tumor markers TPS and CA 15-3 during monitoring of treatment in metastatic breast cancer patients Anticancer Research 16(4b): 2169-2172
Donenko, F.V.; Kabieva, A.O.; Efferth, T. 2013: Tumor-specific blood serum factors as determinants of tumor growth Klinicheskaia Laboratornaia Diagnostika 10: 50
Hoque, M.M.; Adnan, S.D.; Karim, S.; Al-Mamun, M.A.; Faruki, M.A.; Islam, K.; Nandy, S. 2016: Relationship between Serum Iron Profile and Blood Groups among the Voluntary Blood Donors of Bangladesh Mymensingh Medical Journal: Mmj 25(2): 340-348
Kalashnikov, V.V.; Chekhonin, V.P.; Tatarinov, I.S. 1983: Interspecific embryonic antigens in the blood serum of cancer patients Voprosy Onkologii 29(4): 24-29
Kosareva, A.N.; Iakovleva, M.P. 1972: Detection of tumor cells in the peripheral blood of patients with cancer of the uterine cervix Voprosy Onkologii 18(2): 86-87